Moderna Expands Deal With CDMO To Source Raw Material For Coronavirus Vaccine
May 28, 2020 at 15:26 PM EDT
Moderna Inc is progressing rapidly in its program to develop an mRNA vaccine for SARS-CoV-2, codenamed mRNA-1273.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|